Advertisement

Topics

Janus Pharmaceuticals, Inc Company Profile

20:56 EST 12th December 2018 | BioPortfolio

Janus was founded in 2004 by Catalyst Pharma Group Inc. (CPG), a clinical development services company in the United States and aRigen, Inc., a private equity backed bio-medical venture company in Japan. aRigen and CPG identified the value in creating topical formulations of novel anti-infective products discovered in Japan and developing and commercializing these products in the United States.

Location

1111 S. Arroyo Parkway, Suite 200
Pasadena
California
91105
United States of America

Contact

Phone: (626) 568-0762
Fax: (626) 568-8667
Email: ssyed@januspharma.com


News Articles [354 Associated News Articles listed on BioPortfolio]

Two-Faced Molecule Slips between DNA Strands

Named after the two-faced god, newly developed Janus nucleic acid recognition elements target double-stranded DNA or RNA by engaging both strands at once. When strung together within a single-stranded...

Janus Kinase Inhibitors: Emerging Applications in Dermatology

Learn about the use of Janus kinase inhibitors, which have become promising treatment options for dermatologic conditions such as psoriasis, atopic dermatitis, alopecia areata, vilitigo, and more. S...

Janus Global Operations team clears vital Iraqi road of IEDs

LENOIR CITY, Tenn., Aug. 31, 2018 /PRNewswire/ -- The Janus Global Operations team operating in Iraq on behalf of the U.S. Department of State's Office Read more...

Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease

The multiple disease domains affected in psoriatic arthritis (PsA) may make composite endpoints appropriate for assessing changes in disease activity over time. Tofacitinib is an oral Janus kinase inh...

Autoperforation of 2D materials for generating two-terminal memristive Janus particles

$GERN Announces New OS Data from IMbark in Imetelstat-Treated Patients with Intermediate-2 or High-Risk Myelofibrosis and R/R to Janus Kinase Inhibitor Therapy #ASH18 https://globenewswire.com/news-release/2018/12/03/1661241/0/en/Geron-Announces-New-Overa

$GERN Announces New OS Data from IMbark in Imetelstat-Treated Patients with Intermediate-2 or High-Risk Myelofibrosis and R/R to Janus Kinase Inhibitor Therapy #ASH18 https://globenewswire.com/news...

“We have shown that gamma PNA containing a selected set of Janus bases could be developed and could hybridize to both strands of the DNA double helix without undergoing self-hybridization": http://ow.ly/tkiJ30mDdfD 

“We have shown that gamma PNA containing a selected set of Janus bases could be developed and could hybridize to both strands of the DNA double helix without undergoing self-hybridization": htt...

Pfizer's Xeljanz cleared for ulcerative colitis in Europe

Drug becomes the first oral therapy and Janus kinase (JAK) inhibitor available for UC

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]

EYEWASH STATION ADDITIVE CONCENTRATE

PubMed Articles [216 Associated PubMed Articles listed on BioPortfolio]

Drying mediated orientation and assembly structure of amphiphilic Janus particles.

Amphiphilic Janus particles demonstrate unique assembly structures when dried on a hydrophilic substrate. Particle orientations are influenced by amphiphilicity and Janus balance. A three-stage model ...

Simultaneous two drugs release form Janus particles prepared via polymerization-induced phase separation approach.

Seeded emulsion polymerization of 2-dimethylaminoethylamino methacrylate (DMAEMA) was carried out using monodispersed poly(2-hydroxyehtyl methacrylate) (PHEMA) seeds to produce Janus particles. Three ...

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Self-propulsion of aluminum particle-coated Janus droplet in alkaline solution.

Janus droplet motion powered by gas bubbles is studied in this paper. The Janus droplets were fabricated by partially covering one side of an oil droplet with aluminum particles under gravity effect. ...

A Hydrophilic/Hydrophobic Janus Inverse-Opal Actuator via Gradient Infiltration.

Janus/gradient actuating materials have become promising candidates for actuating devices. The fabrication of functional Janus gradient actuators remains a challenge. This paper presents a facile fabr...

Clinical Trials [246 Associated Clinical Trials listed on BioPortfolio]

A Single Center Prospective Randomized Controlled Clinical Study of JANUS Stent in Patients With Coronary Artery Disease

Janus stent is the only marketed drug-eluting stent (DES) without polymer coating as yet in China. The goal of this study is to evaluate the efficacy of JANUS (Tacrolimus eluted stent) i...

This is a Study to Determine the Effect and Safety of an Oral Janus Kinase 2 (JAK2)-Inhibitor in Patients With Multiple Myeloma

The purpose of this study is to determine clinical efficacy and safety of INCB018424, a small molecule Janus kinase (JAK) inhibitor, in patients with refractory or relapsed multiple myelom...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Companies [1343 Associated Companies listed on BioPortfolio]

Janus Pharmaceuticals, Inc

Janus was founded in 2004 by Catalyst Pharma Group Inc. (CPG), a clinical development services company in the United States and aRigen, Inc., a private equity backed bio-medical venture company in Jap...

Janus

We offer a broad range of investment options, but our expertise is in growth and risk-managed funds. Some of us are driven by a never-ending search for an information advantage. Others by an unwaverin...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

Serenity Pharmaceuticals

Founded in 2007 and located in Milford, Pennsylvania, Serenity Pharmaceuticals is focused on developing products that address urinary conditions that impact the health and well-be...

More Information about "Janus Pharmaceuticals, Inc" on BioPortfolio

We have published hundreds of Janus Pharmaceuticals, Inc news stories on BioPortfolio along with dozens of Janus Pharmaceuticals, Inc Clinical Trials and PubMed Articles about Janus Pharmaceuticals, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Janus Pharmaceuticals, Inc Companies in our database. You can also find out about relevant Janus Pharmaceuticals, Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record